Site Members can sign up for company wide alerts
Lawsuit Overview
May 06, 2024 - An investor in shares of Altimmune, Inc. (NASDAQ: ALT) filed a lawsuit in the U.S. District Court for the District of Maryland over alleged violations of Federal Securities Laws by Altimmune, Inc. in connection with certain allegedly false and misleading statements made between December 1, 2023 and April 26, 2024. Gaithersburg, MD based Altimmune, Inc., a clinical stage...
You must register (for free) or login to view the entire case.